探索黄素作为强大的SLC46A3抑制剂:从黄素-SLC46A3相互作用的结构特征的见解

Ryuto Tomabechi1, Naoki Saito2, Daisuke Saito2

  • 1Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan; Laboratory of Pharmaceutics, Kitasato University School of Pharmacy, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.

Biochemical pharmacology
|November 23, 2024
PubMed
概括

黄类药物,如阿皮基宁和黄素,抑制SLC46A3转运体,这对药物输送和细胞功能至关重要. 黄类化合物的基团是这种相互作用的关键,具有治疗潜力.